Lv0
-10 积分 2026-08-24 加入
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study
1天前
已完结
The effect of at least 1-year use of omalizumab without interruption on relapse in patients with chronic spontaneous urticaria
1天前
已完结
Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real‐life data
1天前
已完结
Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria
1天前
已完结
Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens
1天前
已完结
Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
1天前
已完结
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
1天前
已完结
Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria
1天前
已完结
皖公网安备34019202002308
